Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Morote

Showing results (91-100 of 209) with videos related to

Pageof 21
Sort By:
The International Journal of Biological Markers|April 1, 1989
Clinical behaviour of prostatic specific antigen and prostatic acid phosphatase: a comparative studyJ Morote Robles, A Ruibal Morell, J A De Torres Mateos, et al.
Actas Urologicas Espanolas|March 1, 1987
[Evaluation of the specificity of specificity of prostate-specific antigen (PSA) and prostatic acid phosphatase (PAP) in prostate pathology]J Morote Robles, A Ruibal Morell, J A De Torres Mateos, et al.
Actas Urologicas Espanolas|May 7, 2015
Behavior of total and free serum testosterone as a predictor for the risk of prostate cancer and its aggressivenessL Regis, J Planas, A Celma, et al.
Histology and Histopathology|May 13, 2006
Study of microvessel density and the expression of the angiogenic factors VEGF, bFGF and the receptors Flt-1 and FLK-1 in benign, premalignant and malignant prostate tissuesJ Pallares, F Rojo, J Iriarte, et al.
Medicina Clinica|February 1, 1986
[Impotence caused by hydrochlorothiazide]J Palou Redorta, J Morote Robles, J Costa Pagés, et al.
Actas Urologicas Espanolas|July 11, 1998
[Current status of p53 tumor suppressor gene as a possible molecular marker of cancer of the prostate]J A Peña González, J Morote Robles, I M de Torres Ramírez, et al.
Archivos Espanoles De Urologia|October 1, 1990
[Diclofenac sodium therapy in irritating micturition syndrome following TUR for benign prostatic hyperplasia]A Soler Roselló, J Morote Robles, D García Rojo, et al.
Actas Urologicas Espanolas|October 1, 1992
[Clinical course of hormone refractory cancer of the prostate]J Morote, J Vila, M A López-Pacios, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|April 23, 2013
Do patients with metastatic urothelial carcinoma benefit from docetaxel as second-line chemotherapy?R Morales-Barrera, C Suárez, C Valverde, et al.
European Urology|July 27, 1999
Intraindividual variations of total and percent free serum prostatic-specific antigen levels in patients with normal digital rectal examinationJ Morote, C X Raventós, J A Lorente, et al.
Pageof 21

Showing results (91-100 of 209) with videos related to

Sort By:
Pageof 21
The International Journal of Biological Markers|April 1, 1989
Clinical behaviour of prostatic specific antigen and prostatic acid phosphatase: a comparative studyJ Morote Robles, A Ruibal Morell, J A De Torres Mateos, et al.
Actas Urologicas Espanolas|March 1, 1987
[Evaluation of the specificity of specificity of prostate-specific antigen (PSA) and prostatic acid phosphatase (PAP) in prostate pathology]J Morote Robles, A Ruibal Morell, J A De Torres Mateos, et al.
Actas Urologicas Espanolas|May 7, 2015
Behavior of total and free serum testosterone as a predictor for the risk of prostate cancer and its aggressivenessL Regis, J Planas, A Celma, et al.
Histology and Histopathology|May 13, 2006
Study of microvessel density and the expression of the angiogenic factors VEGF, bFGF and the receptors Flt-1 and FLK-1 in benign, premalignant and malignant prostate tissuesJ Pallares, F Rojo, J Iriarte, et al.
Medicina Clinica|February 1, 1986
[Impotence caused by hydrochlorothiazide]J Palou Redorta, J Morote Robles, J Costa Pagés, et al.
Actas Urologicas Espanolas|July 11, 1998
[Current status of p53 tumor suppressor gene as a possible molecular marker of cancer of the prostate]J A Peña González, J Morote Robles, I M de Torres Ramírez, et al.
Archivos Espanoles De Urologia|October 1, 1990
[Diclofenac sodium therapy in irritating micturition syndrome following TUR for benign prostatic hyperplasia]A Soler Roselló, J Morote Robles, D García Rojo, et al.
Actas Urologicas Espanolas|October 1, 1992
[Clinical course of hormone refractory cancer of the prostate]J Morote, J Vila, M A López-Pacios, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|April 23, 2013
Do patients with metastatic urothelial carcinoma benefit from docetaxel as second-line chemotherapy?R Morales-Barrera, C Suárez, C Valverde, et al.
European Urology|July 27, 1999
Intraindividual variations of total and percent free serum prostatic-specific antigen levels in patients with normal digital rectal examinationJ Morote, C X Raventós, J A Lorente, et al.
Pageof 21